What Happened?
San Diego, CA-based Reneo-Pharmaceuticals Appointed Gregory Flesher as President and Chief Executive Officer
About the Company
Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. Many of these diseases are associated with deficits in cellular metabolism and energy production. Our goal is to improve daily function and quality of life of patients suffering from these diseases, most specifically, by improving how their mitochondria work, preserving muscle function and preventing muscle injury, weakness and wasting.
About the Person
Gregory Flesher is President and Chief Executive Officer at Reneo Pharmaceuticals. Previously, Gregory held various senior HR leadership roles in the industry.
Info Source
News
Short Profile